Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine

被引：0
|
作者：
Ralf Buettner
Le Xuan Truong Nguyen
Corey Morales
Min-Hsuan Chen
Xiwei Wu
Lisa S. Chen
Dinh Hoa Hoang
Servando Hernandez Vargas
Vinod Pullarkat
Varsha Gandhi
Guido Marcucci
Steven T. Rosen
机构：
[1] City of Hope Medical Center,Hematology Malignancies Research Institute, Gehr Family Center for Leukemia Research
[2] City of Hope Medical Center,Integrative Genomics Core, Beckman Research Institute
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
来源：
Journal of Hematology & Oncology | / 14卷
关键词：
Acute myeloid leukemia; Oxidative phosphorylation; Fatty acid oxidation; Nucleoside analog; Metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Targeting NF-κB-dependent alkaliptosis for the treatment of venetoclax-resistant acute myeloid leukemia cells
    Zhu, Shan
    Liu, Jiao
    Kang, Rui
    Yang, Minghua
    Tang, Daolin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 562 : 55 - 61
  • [32] Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax
    Nguyen, Thao M.
    Joyce, Paul
    Ross, David M.
    Bremmell, Kristen
    Jambhrunkar, Manasi
    Wong, Sook S.
    Prestidge, Clive A.
    PHARMACEUTICS, 2024, 16 (02)
  • [33] Efficacy and safety of venetoclax-based combination therapy for previously untreated acute myeloid leukemia: a meta-analysis
    He, Hongbo
    Wen, Xiaojia
    Zheng, Huyong
    HEMATOLOGY, 2024, 29 (01)
  • [34] Efficacy and safety of venetoclax combination therapy for relapsed/refractory acute myeloid leukemia: a systematic review and meta-analysis
    Jiao, Ning
    Shi, Lina
    Wang, Shaohua
    Sun, Yonghao
    Bai, Yujun
    Zhang, Dengshan
    BMC CANCER, 2024, 24 (01)
  • [35] Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway
    Tauchi, Tetsuzo
    Moriya, Shota
    Okabe, Seiichi
    Kazama, Hiromi
    Miyazawa, Keisuke
    Takano, Naoharu
    PLOS ONE, 2024, 19 (07):
  • [36] Targeting NEDD8 in pediatric acute myeloid leukemia: an integrated bioinformatics and experimental approach
    Sun, Jian
    Liu, Cui
    Yang, Guangli
    Li, Qian
    An, Yang
    Zhu, Yin
    Zhang, Pingping
    Guan, Yaning
    Peng, Chang
    Du, Zuochen
    Huang, Pei
    Chen, Yan
    HEMATOLOGY, 2025, 30 (01)
  • [37] Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia
    Liu, Qingyang
    Yang, Jingjing
    Lv, Lei
    Zhang, Xiawei
    Li, Meng
    Xu, Lingmin
    Huang, Sai
    Jing, Yu
    Dou, Liping
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [38] Venetoclax with low-dose cytarabine, a forgotten combination in patients with acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review
    Amador-Medina, Lauro Fabian
    Crespo-Solis, Erick
    Turrubiates-Herna, Francisco Javier
    Santibanez-Bedolla, Karla Edith
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S322 - S331
  • [39] Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy
    Honami Sato
    Takahiro Kobayashi
    Yoshihiro Kameoka
    Kazuaki Teshima
    Atsushi Watanabe
    Masahiro Yamada
    Takaya Yamashita
    Shinsuke Noguchi
    Yoshihiro Michisita
    Naohito Fujishima
    Jun Kuroki
    Naoto Takahashi
    International Journal of Clinical Oncology, 2024, 29 : 481 - 492
  • [40] A phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis
    Yang, Jingjing
    Liu, Qingyang
    Zhang, Xiawei
    Jing, Yu
    Le, Ning
    Li, Meng
    Xu, Lingmin
    Zhao, Weijia
    Huang, Sai
    Liu, Daihong
    Dou, Liping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 151
12345